David Azria1,2,3, Barry S Rosenstein4,5. 1. University Federation of Radiation Oncology, Montpellier Cancer Institute (ICM), Montpellier, France. 2. MUSE, Montpellier University, Montpellier, France. 3. INSERM U1194 (IRCM), SIRIC Montpellier Cancer (Grant INCa_Inserm_DGOS_12553), Montpellier, France. 4. Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Barry.Rosenstein@mssm.edu. 5. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Barry.Rosenstein@mssm.edu.
Authors: Sarah L Kerns; Laura Fachal; Leila Dorling; Gillian C Barnett; Andrea Baran; Derick R Peterson; Michelle Hollenberg; Ke Hao; Antonio Di Narzo; Mehmet Eren Ahsen; Gaurav Pandey; Søren M Bentzen; Michelle Janelsins; Rebecca M Elliott; Paul D P Pharoah; Neil G Burnet; David P Dearnaley; Sarah L Gulliford; Emma Hall; Matthew R Sydes; Miguel E Aguado-Barrera; Antonio Gómez-Caamaño; Ana M Carballo; Paula Peleteiro; Ramón Lobato-Busto; Richard Stock; Nelson N Stone; Harry Ostrer; Nawaid Usmani; Sandeep Singhal; Hiroshi Tsuji; Takashi Imai; Shiro Saito; Rosalind Eeles; Kim DeRuyck; Matthew Parliament; Alison M Dunning; Ana Vega; Barry S Rosenstein; Catharine M L West Journal: J Natl Cancer Inst Date: 2020-02-01 Impact factor: 13.506